➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
Colorcon
Merck
Dow
Mallinckrodt

Last Updated: September 22, 2020

DrugPatentWatch Database Preview

Litigation Details for Takeda Pharmaceutical Company Limited v. Accord Healthcare, Inc. (S.D.N.Y. 2011)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Takeda Pharmaceutical Company Limited v. Accord Healthcare, Inc. (S.D.N.Y. 2011)

Docket   Start Trial Date Filed 2011-09-12
Court District Court, S.D. New York Date Terminated 2011-10-31
Cause 35:271 Patent Infringement Assigned To
Jury Demand None Referred To
Parties ACCORD HEALTHCARE, INC.; TAKEDA PHARMACEUTICAL COMPANY LIMITED; TAKEDA PHARMACEUTICALS NORTH AMERICA, INC.
Patents 6,166,043; 6,172,090; 6,211,205; 6,271,243; 6,303,640; 6,329,404
Attorneys Adam Philllip Samansky; Andre K. Cizmarik; Anthony Joseph Viola; Barbara L. Moore; David G. Conlin; Kathleen B. Carr; Zachary Winthrop Silverman
Firms Edwards Angell Palmer & Dodge LLP; Edwards Angell Palmer & Dodge LLP - MA; Edwards Angell Palmer & Dodge, LLP; Edwards Angell Palmer & Dodge, LLP (NYC)
Link to Docket External link to docket
Small Molecule Drugs cited in Takeda Pharmaceutical Company Limited v. Accord Healthcare, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Takeda Pharmaceutical Company Limited v. Accord Healthcare, Inc. (S.D.N.Y. 2011)

Date Filed Document No. Description Snippet Link To Document
2011-09-12 1 Complaint of the ‘404 patent, which expires on June 19, 2016. 16. United States Patent No. 6,166,043 (“the ‘043 … 584 patent, the ‘404 patent, the ‘043 patent, the ‘090 patent, the ‘205 patent, the ‘243 patent, and … 4 of 27 The Patents in Suit 12. United States Patent No. 5,965,5 84 (“the ‘584 patent”), entitled “…'l`h_is is an action for patent infringement arising under the patent laws of the United States, Title…assignment of the ‘584 patent, which expires on June 19, 2016. 14. United States Patent No. 6,329,404 (“the External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Express Scripts
AstraZeneca
McKesson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.